Vaporised nicotine products versus oral forms of nicotine replacement therapy (NRT) products for tobacco smoking cessation among low-socioeconomic status (low-SES) smokers
- Conditions
- SmokingMental Health - AddictionPublic Health - Other public health
- Registration Number
- ACTRN12617001324303
- Lead Sponsor
- niversity of New South Wales
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- All
- Target Recruitment
- 868
Participants will be at least 18 years of age; current daily smoker; motivated and willing to make a quit attempt using medications (NRT/VNP); speak English; able to provide verbal informed consent; receipt of government pension or allowance (proxy for low-SES); have a phone we contact them on; and willing to complete two telephone check-in calls and baseline and follow-up telephone interviews. The term current smoker” in this trial will refer to those who use either factory-made or roll-own cigarettes.
Women who are pregnant, breastfeeding or planning to become pregnant in the next 12 months will be excluded from this trial, as will current users of smoking cessation medications (i.e., NRT, buproprion [Zyban], clonidine, nortriptyline, electronic nicotine cigarettes ), or those who are participating in another smoking cessation program or study. People will also be excluded if they report any of the following medical conditions in the previous three months: serious chronic lung diseases, arrhythmia, heart attack, stroke, or severe angina.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Carbon monoxide verified six-month continuous abstinence (smoking not more than five cigarettes) from the quit date[8 month follow-up from baseline]
- Secondary Outcome Measures
Name Time Method